Krazati

Active Ingredient(s): Adagrasib
FDA Approved: * December 12, 2022
Pharm Company: * MIRATI THERAPEUTICS, INC
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Krazati 200 mg Oral Tablet, Coated
NDC: 80739-812
Labeler:
Mirati Therapeutics, Inc